The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...

The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.

The new single-dose prefilled syringes will be available in 40 USP units/0.5mL and 80 USP units/mL dosage strengths. The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel ...

Cortrophin Gel is a prescription medicine that is injected subcutaneously or intramuscularly indicated for severe acute and ...

The Global Prefilled Syringes Market was valued at $5.43 billion in 2022 and is projected to reach $10.59 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.70% during the forecast ...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) ...

To gain deeper insights into the role of pre-filled syringes in patient-centric packaging, we spoke with Dexter Tjoa, CEO of ...

Halozyme Therapeutics sees strong Q4 2024 growth, driven by ENHANZE platform royalties. Click here to find out why HALO stock ...

The prefilled syringe reduces administration steps for patients using Cortrophin Gel, which remains available in 5 mL and 1 mL vials. The company noted that the new prefilled syringe reduces the ...

Q4 2024 Earnings Call Transcript March 12, 2025 Operator: Greetings. And welcome to the KORU Medical Systems’ Fourth Quarter ...